Laurie Ann Gilje, LPN | |
1712 5th Ave Ne, Beulah, ND 58523-6151 | |
(507) 358-7482 | |
Not Available |
Full Name | Laurie Ann Gilje |
---|---|
Gender | Female |
Speciality | Technician - Personal Care Attendant |
Location | 1712 5th Ave Ne, Beulah, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417617549 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Laurie Ann Gilje, LPN 1712 5th Ave Ne, Beulah, ND 58523-6151 Ph: (507) 358-7482 | Laurie Ann Gilje, LPN 1712 5th Ave Ne, Beulah, ND 58523-6151 Ph: (507) 358-7482 |
News Archive
An analysis of data from two nationally representative surveys reports a greater proportion of U.S. adults perceived electronic cigarettes to be as, or more, harmful than cigarettes and a decreasing proportion of U.S. adults perceived e-cigarettes to be less harmful than cigarettes.
Medical researchers at the University of Alberta have discovered a potential new drug target for Multiple Sclerosis that could prevent physical disability associated with the disease, once a new drug is developed.
A diagnosis of pancreatic cancer is often a death sentence because current chemotherapies have little impact on the disease.
A case study, "Biomimicry: Streamlining the Front End of Innovation for Environmentally Sustainable Products," shows that biomimicry, a relatively new field that seeks to emulate nature to find solutions to human problems, can potentially expand intellectual property, increase energy savings and accelerate product innovation.
A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab improved patient outcome. Patients who received the combined therapy had a 78 percent reduction in new brain lesions and a 70 percent reduction in total lesions, along with other significant clinical improvements.
› Verified 8 days ago